Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Jin, Qiming ^a   Wei, Guobao ^b   Lin, Zhao ^a   Sugai, James V ^a   Lynch, Samuel E ^c   Ma, Peter X ^b   Giannobile, William V ^a,b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BioMimetic Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BIOMATERIAL; CHEMOKINE; COMPLEMENTARY DNA; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; MICROSPHERE; MOLECULAR SCAFFOLD; POLYMER; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; CXCL1 PROTEIN, RAT; CXCL2 PROTEIN, RAT; LACTIC ACID; NANOMATERIAL; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; POLYGLYCOLIC ACID; POLYLACTIC ACID; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTECHNOLOGY; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; SOFT TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; WOUND HEALING; ANIMAL; BLOOD VESSEL; CELL MOTION; CHEMISTRY; GENETICS; IMPLANT; METABOLISM; PHYSIOLOGY; RAT;

RATTUS;

ANIMALS; BLOOD VESSELS; CELL MOVEMENT; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHEMOKINE CXCL5; GENE EXPRESSION PROFILING; IMPLANTS, EXPERIMENTAL; LACTIC ACID; MICROSPHERES; NANOSTRUCTURES; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET-DERIVED GROWTH FACTOR; POLYGLYCOLIC ACID; POLYMERS; RATS; RECOMBINANT PROTEINS; TISSUE ENGINEERING; WOUND HEALING;

EID: 45849112200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001729     Document Type: Article

References (39)

1. Kaigler D, Cirelli JA, Giannobile WV (2006) Growth factor delivery for oral and periodontal tissue engineering. Expert Opin Drug Deliv 3: 647-662.
2. Langer R, Tirrell DA (2004) Designing materials for biology and medicine. Nature 428: 487-492.
3. Wei G, Jin Q, Giannobile WV, Ma PX (2007) The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28: 2087-2096.
4. Ostman A, Heldin CH (2001) Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res 80: 1-38.
5. Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316.
6. Kaminski WE, Lindahl P, Lin NL, Broudy VC, Crosby JR, et al. (2001) Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood 97: 1990-1998.
7. Alvarez RH, Kantarjian HM, Cortes JE (2006) Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81: 1241-1257.
8. Cooke JW, Sarment DP, Whitesman LA, Miller SE, Jin Q, et al. (2006) Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng 12: 1441-1450.
9. Taba M Jr, Jin Q, Sugai JV, Giannobile WV (2005) Current concepts in periodontal bioengineering. Orthod Craniofac Res 8: 292-302.
10. Heldin CH, Ostman A, Ronnstrand L (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378: F79-113.
11. Heldin P, Laurent TC, Heldin CH (1989) Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 258: 919-922.
12. Kaplan DR, Chao FC, Stiles CD, Antoniades HN, Scher CD (1979) Platelet alpha granules contain a growth factor for fibroblasts. Blood 53: 1043-1052.
13. Rosenkranz S, Kazlauskas A (1999) Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors 16: 201-216.
14. Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin GR (1982) Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol 92: 584-588.
15. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT (2006) Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 116: 237-248.
16. Hsieh PC, MacGillivray C, Gannon J, Cruz FU, Lee RT (2006) Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation 114: 637-644.
17. Chin A, Zheng J, Duignan IJ, Edelberg JM (2006) PDGF-AB-based functional cardioprotection of the aging rat heart. Exp Gerontol 41: 63-68.
18. Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, et al. (2006) The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 48: 2315-2323.
19. Steed DL (2006) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117: 143S-149S; discussion 150S-151S.
20. Sarment DP, Cooke JW, Miller SE, Jin Q, McGuire MK, et al. (2006) Effect of rhPDGF-BB on bone turnover during periodontal repair. J Clin Periodontol 33: 135-140.
21. Grayson AC, Voskerician G, Lynn A, Anderson JM, Cima MJ, et al. (2004) Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J Biomater Sci Polym Ed 15: 1281-1304.
22. Lee S, Kim MS, Kim JS, Park HJ, Woo JS, et al. (2006) Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical antisolvent precipitation technique. J Microencapsul 23: 741-749.
23. Wei G, Jin Q, Giannobile WV, Ma PX (2006) Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release 112: 103-110.
24. Jin QM, Zhao M, Webb SA, Berry JE, Somerman MJ, et al. (2003) Cementum engineering with three-dimensional polymer scaffolds. J Biomed Mater Res A 67: 54-60.
25. Ryseck RP, MacDonald-Bravo H, Mattei MG, Bravo R (1989) Cloning and sequence of a secretory protein induced by growth factors in mouse fibroblasts. Exp Cell Res 180: 266-275.
26. Faisant N, Siepmann J, Benoit JP (2002) PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci 15: 355-366.
27. Zolnik BS, Leary PE, Burgess DJ (2006) Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 112: 293-300.
28. Issa R, Xie S, Lee KY, Stanbridge RD, Bhavsar P, et al. (2006) GRO-alpha regulation in airway smooth muscle by IL-1beta and TNF-alpha: role of NF-kappaB and MAP kinases. Am J Physiol Lung Cell Mol Physiol 291: L66-74.
29. Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in antiapoptotic PDGF signaling. Nature 401: 86-90.
30. Chandrasekar B, Melby PC, Saran HM, Raveendran M, Perla RP, et al. (2003) Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem 278: 4675-4686.
31. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10: 405-455.
32. Wang XT, Liu PY, Tang JB (2006) PDGF gene therapy enhances expression of VEGF and bFGF genes and activates the NF-kappaB gene in signal pathways in ischemic flaps. Plast Reconstr Surg 117: 129-137; discussion 138-129.
33. Wood LD, Farmer AA, Richmond A (1995) HMGI(Y) and Spl in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res 23: 4210-4219.
34. Fernandez EJ, Lolis E (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42: 469-499.
35. Laing KJ, Secombes CJ (2004) Chemokines. Dev Comp Immunol 28: 443-460.
36. Ramseier CA, Abramson ZR, Jin O, Giannobile WV (2006) Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am 50: 245-263, ix.
37. Nirodi CS, Devalaraja R, Nanney LB, Arrindell S, Russell S, et al. (2000) Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen 8: 371-382.
38. Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, et al. (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165: 5269-5277.
39. Lindahl P, Johansson BR, Leveen P, Betsholtz C (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.